SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-182301
Filing Date
2024-07-22
Accepted
2024-07-22 17:30:07
Documents
7
Effectiveness Date
2024-07-22

Document Format Files

Seq Description Document Type Size
1 S-8 d874189ds8.htm S-8 58302
2 EX-5.1 d874189dex51.htm EX-5.1 8493
3 EX-23.1 d874189dex231.htm EX-23.1 1651
4 EX-99.3 d874189dex993.htm EX-99.3 172477
5 EX-99.6 d874189dex996.htm EX-99.6 79022
6 EX-FILING FEES d874189dexfilingfees.htm EX-FILING FEES 30210
7 GRAPHIC g874189g0719093103211.jpg GRAPHIC 2537
  Complete submission text file 0001193125-24-182301.txt   354855
Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Filer) CIK: 0001817241 (see all company filings)

IRS No.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280950 | Film No.: 241132393
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)